The purpose of this study was to evaluate the clinical characteristics of NSCLC patients to distinguish between ALK&ROS1 gene rearrangement, EGFR mutation, and non‐ALK&ROS1/EGFR mutation. Here, ALK is linked to non-small cell lung carcinoma.